Syra Health Announces Third Quarter 2023 Financial Results
Retrieved on:
Tuesday, November 14, 2023
EBITDA, Health education, E&I, Population health, Epidemiology, Conference call, Rural Business-Cooperative Service, Emergency, Mental health, Depreciation, EMR, Workforce, ASC, Benchmarking, GAAP, Radiology, IPO, Public health, Table, Growth, Health, Addiction, Digital health, Interest, Family, Table A, Mental, DBH, Pharmaceutical industry, Video game, Clothing, Nursing, SS Syren, Conference
CARMEL, Ind., Nov. 14, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, today announced its financial results for the third quarter of 2023 for the period ended September 30, 2023.
Key Points:
- Conference call will be held today, Tuesday, November 14 at 9:00am ET
CARMEL, Ind., Nov. 14, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, today announced its financial results for the third quarter of 2023 for the period ended September 30, 2023. - Launched Syrenity, a mental health product that proactively identifies the negative factors impacting mental health and integrates telehealth for mental health prevention and treatment.
- Sandeep Allam, Executive Chairman and President of Syra Health, said, "We completed our successful initial public offering in October 2023.
- Net Loss for the quarter ended September 30, 2023, was $(354,376), compared to $(354,535) in the third quarter of 2022.